{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:14:11Z","timestamp":1783728851830,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015773","name":"Ignacio Ch\u00e1vez National Institute of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cct.2026.108385","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:23:23Z","timestamp":1782314603000},"page":"108385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and\/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial"],"prefix":"10.1016","volume":"167","author":[{"given":"Maria Jose","family":"Santa-Ana-Bayona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Ponce-Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto H.","family":"Acosta-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Morales-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique C.","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Gonzalez-Trejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Rodrigo","family":"Espinosa-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor J.","family":"Solis Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermes","family":"Ilarraza-Lomel\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Alexanderson-Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoana","family":"Leyva-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neftali Eduardo","family":"Antonio-Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilda","family":"Espinola-Zavaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2026.108385_bb0005","unstructured":"[Internet]. [cited 2025 Mar 25]. Available from: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/900-world-fact-sheet.pdf."},{"issue":"5","key":"10.1016\/j.cct.2026.108385_bb0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaccao.2024.07.016","article-title":"Anthracycline cardiotoxicity in adult cancer patients: JACC: cardioOncology state-of-the-art review","volume":"6","author":"Camilli","year":"2024","journal-title":"JACC CardioOncol."},{"issue":"10","key":"10.1016\/j.cct.2026.108385_bb0015","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1200\/JCO.2015.64.5515","article-title":"Cardiac surveillance guidelines for trastuzumab-containing therapy in early-stage breast cancer: getting to the heart of the matter","volume":"34","author":"Dang","year":"2016","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.cct.2026.108385_bb0020","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.6004\/jnccn.2018.0078","article-title":"Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Denlinger","year":"2018","journal-title":"J Natl Compr Cancer Netw"},{"issue":"12","key":"10.1016\/j.cct.2026.108385_bb0025","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/ejhf.2051","article-title":"Is cardio-oncology a rapidly growing field of precision medicine?","volume":"22","author":"Farmakis","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"41","key":"10.1016\/j.cct.2026.108385_bb0030","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.cct.2026.108385_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaccao.2024.09.014","article-title":"Cardiovascular safety in oncology clinical trials: JACC: CardioOncology primer","volume":"7","author":"Bonaca","year":"2025","journal-title":"JACC CardioOncology."},{"issue":"4","key":"10.1016\/j.cct.2026.108385_bb0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an international cardio-oncology society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.cct.2026.108385_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12872-021-01970-2","article-title":"A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol","volume":"21","author":"D\u00edaz-Balboa","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.cct.2026.108385_bb0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pcad.2024.02.002","article-title":"Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: the ONCORE randomized controlled trial","volume":"85","author":"D\u00edaz-Balboa","year":"2024","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.cct.2026.108385_bb0055","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ijcard.2022.09.075","article-title":"Impact of a COmprehensive cardiac REhabilitation framework among high cardiovascular risk cancer survivors: protocol for the CORE trial","volume":"371","author":"Viamonte","year":"2023","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.cct.2026.108385_bb0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaccao.2023.08.008","article-title":"Incorporating exercise training into cardio-oncology care","volume":"5","author":"Wilson","year":"2023","journal-title":"JACC CardioOnc."},{"issue":"1","key":"10.1016\/j.cct.2026.108385_bb0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s13063-019-3499-9","article-title":"Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial","volume":"20","author":"Antunes","year":"2019","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.cct.2026.108385_bb0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13102-023-00634-2","article-title":"High-intensity exercise prescription guided by heart rate variability in breast cancer patients: a study protocol for a randomized controlled trial","volume":"15","author":"Lav\u00edn-P\u00e9rez","year":"2023","journal-title":"BMC Sports Sci. Med. Rehabil."},{"issue":"6","key":"10.1016\/j.cct.2026.108385_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/s12170-013-0354-5","article-title":"Physical activity and exercise for secondary prevention among patients with cardiovascular disease","volume":"7","author":"Darden","year":"2013","journal-title":"Curr Cardiovasc Risk Rep."},{"issue":"11","key":"10.1016\/j.cct.2026.108385_bb0080","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jacc.2022.07.004","article-title":"Exercise for primary and secondary prevention of cardiovascular disease: JACC focus seminar 1\/4","volume":"80","author":"Tucker","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"21","key":"10.1016\/j.cct.2026.108385_bb0085","doi-asserted-by":"crossref","first-page":"e997","DOI":"10.1161\/CIR.0000000000000679","article-title":"Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association","volume":"139","author":"Gilchrist","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cct.2026.108385_bb0090","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise guidelines for Cancer survivors: consensus statement from international multidisciplinary roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.cct.2026.108385_bb0095","unstructured":"WHO data set [Internet]. [cited 2025 Mar 25]. Available from: https:\/\/www.who.int\/clinical-trials-registry-platform\/network\/who-data-set."},{"key":"10.1016\/j.cct.2026.108385_bb0100","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2026.108385_bb0105","unstructured":"ACSM's Guidelines for Exercise Testing and Prescription [Internet]. [cited 2025 Mar 25]. Available from: https:\/\/www.wolterskluwer.com\/en\/know\/acsm\/guidelines-for-exercise-testing-and-prescription."},{"issue":"5","key":"10.1016\/j.cct.2026.108385_bb0110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/occmed\/kqx063","article-title":"The Borg rating of perceived exertion (RPE) scale","volume":"67","author":"Williams","year":"2017","journal-title":"Occup. Med."},{"issue":"2","key":"10.1016\/j.cct.2026.108385_bb0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1249\/01.MSS.0000048831.15016.2A","article-title":"Concurrent validation of the OMNI perceived exertion scale for resistance exercise","volume":"35","author":"Robertson","year":"2003","journal-title":"Med Sci Sports Exerc."},{"issue":"6","key":"10.1016\/j.cct.2026.108385_bb0120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology breast cancer survivorship care guideline","volume":"34","author":"Runowicz","year":"2016","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.cct.2026.108385_bb0125","first-page":"711","article-title":"Initiating exercise interventions to promote wellness in Cancer patients and survivors","volume":"31","author":"Schwartz","year":"2017","journal-title":"Oncol Williston Park N."},{"issue":"22","key":"10.1016\/j.cct.2026.108385_bb0130","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1200\/JCO.22.00687","article-title":"Exercise, diet, and weight management during Cancer treatment: ASCO guideline","volume":"40","author":"Ligibel","year":"2022","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.cct.2026.108385_bb0135","series-title":"Oncolog\u00eda general para profesionales de salud de primer contacto [Internet]","first-page":"433","author":"Samuel Rivera Rivera","year":"2018"},{"issue":"18","key":"10.1016\/j.cct.2026.108385_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000559","article-title":"Routine assessment and promotion of physical activity in healthcare settings: a scientific statement from the American Heart Association","volume":"137","author":"Lobelo","year":"2018","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.cct.2026.108385_bb0145","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.medcli.2010.11.028","article-title":"Validaci\u00f3n de la versi\u00f3n espa\u00f1ola del Functional Assessment of Cancer Therapy Questionnaire for Breast Cancer (FACT-B+4)","volume":"137","author":"Belmonte Mart\u00ednez","year":"2011","journal-title":"Med. Cl\u00ednica"},{"issue":"3","key":"10.1016\/j.cct.2026.108385_bb0150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/insr.12149","article-title":"Sample size calculations for clustered and longitudinal outcomes in clinical research","volume":"83","author":"Neeman","year":"2015","journal-title":"Int. Stat. Rev."},{"issue":"Supplement_1","key":"10.1016\/j.cct.2026.108385_bb0155","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.3188","article-title":"Validation of the HFA-ICOS risk assessment tool with real-world data from a prospective cohort of breast cancer patients in treatment with anthracyclines and trastuzumab","volume":"45","author":"Guerra","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cct.2026.108385_bb0160","article-title":"Cardio-oncology: a myriad of relationships between cardiovascular disease and cancer","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cct.2026.108385_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s40959-025-00319-4","article-title":"Incidence and risk factors of trastuzumab-induced cardiac dysfunction in a predominantly Hispanic South Texas population: a descriptive study","volume":"11","author":"Sharma","year":"2025","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.cct.2026.108385_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/795602","article-title":"Chemotherapy-induced cardiotoxicity: overview of the roles of oxidative stress","volume":"2015","author":"Angsutararux","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cct.2026.108385_bb0175","article-title":"Anthracycline-induced cardiotoxicity: an overview from cellular structural perspective","volume":"179","author":"Li","year":"2024","journal-title":"Biomed Pharmacother Biomedecine Pharmacother."},{"issue":"1","key":"10.1016\/j.cct.2026.108385_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"JV","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"7","key":"10.1016\/j.cct.2026.108385_bb0185","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.cct.2026.108385_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01262","article-title":"Updates in anthracycline-mediated cardiotoxicity","volume":"9","author":"Nebigil","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cct.2026.108385_bb0195","first-page":"1","article-title":"Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures","volume":"2","author":"Yu","year":"2016","journal-title":"Cardio-Oncol Lond Engl."},{"issue":"18","key":"10.1016\/j.cct.2026.108385_bb0200","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1113\/JP270656","article-title":"Mitochondria in the middle: exercise preconditioning protection of striated muscle","volume":"594","author":"Lawler","year":"2016","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.cct.2026.108385_bb0205","first-page":"399","article-title":"Aerobic exercise training as a potential cardioprotective strategy to attenuate doxorubicin-induced cardiotoxicity","volume":"19","author":"Kouzi","year":"2016","journal-title":"J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm."},{"issue":"5","key":"10.1016\/j.cct.2026.108385_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051102","article-title":"Early moderate intensity aerobic exercise intervention prevents doxorubicin-caused cardiac dysfunction through inhibition of cardiac fibrosis and inflammation","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.cct.2026.108385_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1406247","article-title":"An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity","volume":"15","author":"Xie","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.cct.2026.108385_bb0220","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jamacardio.2023.3558","article-title":"Cardio-oncology rehabilitation for cancer survivors with high cardiovascular risk","volume":"8","author":"Viamonte","year":"2023","journal-title":"JAMA Cardiol."},{"issue":"6","key":"10.1016\/j.cct.2026.108385_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100424","article-title":"TITAN trial","volume":"2","author":"Kirkham","year":"2023","journal-title":"JACC Adv."},{"issue":"2","key":"10.1016\/j.cct.2026.108385_bb0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/HCR.0000000000000719","article-title":"Cardiac rehabilitation improves fitness in patients with subclinical markers of cardiotoxicity while receiving chemotherapy: a randomized controlled study","volume":"43","author":"Kerrigan","year":"2023","journal-title":"J. Cardiopulm. Rehabil. Prev."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426001710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426001710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:30:32Z","timestamp":1783726232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714426001710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"alternative-id":["S1551714426001710"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2026.108385","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of a CArdiac Rehabilitation program on the Prevention of CardioTOXicity in Breast Cancer patients undergoing treatment with anthracyclines and\/or trastuzumab (CARPTOX-BC) trial: a randomized, active control group, open-label trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2026.108385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108385"}}